在博世新能源汽车核心部件及自动驾驶研发制造基地，范波详细了解核心部件研发、智能制造流程，对企业 多次投资加码苏州表示赞赏。他希望企业坚定发展信心，推动更多前沿技术和高端项目落地苏州。来到三星电子 （苏州）半导体有限公司，范波参观企业展厅，听取生产运营情况介绍，鼓励企业提升先进制造能级，不断增强 全球市场竞争力。 昨天（1月5日），市委书记范波调研我市外资企业发展工作。他强调，要深入学习贯彻党的二十届四中全会 精神和习近平总书记会见国际工商界代表时的重要讲话精神，认真落实党中央、国务院决策部署及省委、省政府 工作要求，突出创新引领，强化开放赋能，打造一流营商环境，不断增创高水平开放新优势，为苏州高质量发展 提供有力支撑。 倪黎祥 摄 外资企业是中国式现代化的重要参与者，是中国改革开放和创新创造的重要参与者，是中国联通世界、融入 经济全球化的重要参与者。范波强调，要坚定不移扩大对外开放，深化开放创新综合试验，鼓励外资企业利润再 投资和设立研发中心、地区总部，提升城市产业发展核心竞争力。要着力打造市场化、法治化、国际化一流营商 环境，维护市场公平竞争，健全外商投资全生命周期服务保障体系，深入开展服务企业、服务项目、 ...

长江江苏段全长400多公里，大江两岸从"拥江发展"走向"跨江融合"，离不开过江通道建设的加速推 进。 近日，常州21位企业家组团来到长江对岸的泰州泰兴市虹桥镇，双方围绕深化常泰合作、推进跨江融合 开展交流探讨。去年9月9日，常泰长江大桥通车运营，常泰两地车程从1小时20分钟缩短至20分钟。"时 间的缩短，带来心理距离的拉近。"泰兴虹桥工业园区管委会主任李东介绍，大桥开通至今，已有超60 批次苏南企业、团队前来考察。 一桥连通， "枢纽之城"有了"硬支撑" □ 本报记者赵晓勇 通讯员吉唯哲徐路孙刚 常泰经济协同发展的故事，不仅发生在虹桥镇。早在2013年，常州中进医疗器材股份有限公司就在泰州 海陵区九龙镇设立工厂，引进国际先进水平的轮椅生产线及全套生产、检测设备，年产轮椅10万 套。"九龙镇在自行车、摩托车配件产业上，有着深厚底蕴，与我们形成了产业配套。"公司总经理助理 袁丽介绍，九龙镇及周边集聚了四五十家配套商，"这些配套商，除了供应泰州公司，平均2天左右也会 向常州公司送一次货，常泰长江大桥的通车为公司人员通勤带来了极大便利。" 长三角一体化发展的大背景下，位于上海大都市圈和南京都市圈交界处的无锡、常州、泰 ...

Group 1 - The 2026 Tariff Adjustment Plan aims to scientifically adjust import provisional tax rates, optimize tariff categories, and continue implementing agreement and preferential tax rates, which will help lead the development of new productive forces and meet the growing needs of the people [1] - The plan includes three main aspects: adjusting import provisional tax rates, optimizing tariff categories, and continuing to implement agreement and preferential tax rates [1] - In the adjustment of import provisional tax rates, 935 items will have provisional tax rates lower than the most-favored-nation rate, enhancing the linkage between domestic and international markets [1] Group 2 - The adjustment in the petrochemical sector includes items such as bio-aviation kerosene and lithium-ion battery recycled black powder, reflecting the national policy to support the green and low-carbon transition of fossil energy [2] - The reduction of import tariffs on medical products like artificial blood vessels and diagnostic kits for infectious diseases aims to improve public health and enhance the well-being of the population [2] - The adjustment of tariffs on certain medical devices is expected to increase the supply of quality products and reduce the medical burden on consumers [2] Group 3 - The optimization of tariff categories will include new entries such as intelligent bionic robots and bio-aviation kerosene, with the total number of tariff categories reaching 8,972 [3] - The plan continues to implement agreement tax rates for certain imported goods from 34 trade partners, promoting regional integration and economic cooperation [3] - China aims to provide 100% zero-tariff treatment for products from 43 least developed countries, showcasing its commitment to global development amidst rising trade protectionism [3]

12月9日，香港科技大学利丰供应链研究院（以下简称"研究院"）在全球供应链大会2025上发布《2025 年全球供应链报告》。报告指出，当下各国为降低对中国供应链依赖所采取的措施，并未导致预期中 的"脱钩"，反而激发中国企业开启新一轮更深层次的全球布局。 2025年全球供应链报告 报告以电动车、太阳能、服装及医疗器材四大产业为例，深入剖析了地缘政治紧张、人工智能技术应用 及强制性ESG（环境、社会及治理）法规，如何从根本上改变全球制造和采购格局。 研究院研究主管钱慧敏女士表示："最值得关注的发现是，那些意在削弱中国制造地位的贸易壁垒，正 在产生相反效果。中国企业并未退缩，反而以更快的速度将资本、技术与生产能力布局全球，从传统供 应商加速向跨国网络的协调者转型。他们在东南亚、中东、北非和欧洲等地推进本地化生产，同时牢牢 掌握核心技术、品牌与上游关键材料。这并非简单的'脱钩'，而是迈向一种更加复杂、相互依存的供应 链新格局。" 人工智能正在全面改变产品设计、生产规划、库存管理与质量监控的模式，而智能工厂与先进机器人技 术则重新定义了生产区位的经济性。同时，各企业正竞相研发新一代材料与零部件，试图主动打破现有 的供应 ...

Core Viewpoint - Sichuan Province is advancing the construction of Yibin Sanjiang New Area, aiming to establish a southern opening and cooperation window, with the newly formulated "Yibin Sanjiang New Area Regulations" set to take effect on December 1 this year [1][4]. Group 1: Economic Development - Yibin Sanjiang New Area, established in February 2020, has shown strong development momentum, with regional GDP projected to rise from 22.15 billion yuan in 2020 to 60 billion yuan by 2024 [1][3]. - In the first half of this year, the regional GDP reached 27.3 billion yuan, growing by 8.2%, while the industrial output value of above-scale enterprises was 79.53 billion yuan, increasing by 9.6% [1][3]. Group 2: Regulatory Framework - The new regulations are designed to adapt to the needs of the New Area's development and to solidify the achievements of recent reforms [3]. - The regulations define the New Area's functions, including becoming a demonstration zone for green and low-carbon development, an innovative modern industrial cluster, and a pioneer in southward opening and cooperation [3][4]. Group 3: Industrial Focus - The regulations emphasize high-end industries, integration into global industrial chains, and the development of strategic emerging industries, including power batteries, new energy vehicles, electronic information, high-end equipment manufacturing, and medical devices [3][4]. - The New Area aims to enhance its open economy level, attract foreign investment, and support enterprises in expanding internationally [4].

Core Points - A jury in Los Angeles found Johnson & Johnson liable in a lawsuit regarding its baby powder causing cancer, ordering the company to pay $966 million (approximately 6.878 billion RMB) to the family of a woman who died from mesothelioma [1][2] - The lawsuit was initiated by the family of Mae Moore, who passed away in 2021, claiming that the company's talc baby powder contained asbestos, a known carcinogen [1][2] - Johnson & Johnson plans to appeal the verdict, arguing that the evidence presented was based on "junk science" and that the ruling is "absurd and unconstitutional" [2][3] Legal and Financial Implications - The court ordered Johnson & Johnson to pay $16 million in compensatory damages and $950 million in punitive damages, although the punitive damages may be reduced on appeal due to Supreme Court guidelines [2] - The company is currently facing lawsuits from over 67,000 plaintiffs, primarily related to ovarian cancer claims, with a smaller number alleging mesothelioma [3] - To manage the extensive litigation, Johnson & Johnson is employing the "Texas two-step bankruptcy" strategy, which involves transferring its talc liabilities to a subsidiary and then seeking bankruptcy protection for that entity [3] Product and Market Context - Johnson & Johnson ceased the sale of talc-based baby powder in the U.S. in 2020, switching to a cornstarch-based formula due to safety concerns stemming from misinformation affecting consumer perceptions [2][5] - The company has been selling talc baby powder globally for over a century, but has faced ongoing lawsuits regarding its safety, particularly concerning the potential presence of asbestos in talc [2][3]

Group 1 - The stock of Zhongjin Medical (ZJYL) opened up by 6.79% on August 22, reaching $0.61 per share, with a total market capitalization of $95.4781 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57%, and a net profit attributable to the parent company of $3.6759 million, reflecting a year-on-year increase of 27.71% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which has been recognized as a national high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment specifically designed for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The stock price of Zhongjin Medical (ZJYL) increased by 3.57% on August 22, reaching $0.592 per share, with a trading volume of $23,100 and a total market capitalization of $92.5976 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57%, and a net profit attributable to the parent company of $3.6759 million, reflecting a year-on-year increase of 27.71% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which has been recognized as a high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The stock price of Zhongjin Medical (ZJYL) increased by 5.62% on August 13, reaching $0.672 per share, with a total market capitalization of $10.5 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57%, and a net profit attributable to the parent company of $3.6759 million, reflecting a year-on-year increase of 27.71% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company primarily operating through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which has been recognized as a national high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The core viewpoint of the article highlights the positive financial performance of Zhongjin Medical (ZJYL), with a stock price increase of 2.78% and a market capitalization of $103 million as of August 8 [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57% [1] - The net profit attributable to the parent company reached $3.6759 million, showing a year-on-year increase of 27.71% [1] Group 2 - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that operates primarily through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd. [1] - The subsidiary was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] - The company specializes in the research and manufacturing of high-end rehabilitation equipment, with a product range that includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations [1]